WHO ICTRP trial
Multiple Dose Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics…
JPRN-jRCT2031230177 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2031230177 |
|---|---|
| Public title | Multiple Dose Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of BMS-986322 in Participants with Moderate-to-Severe Psoriasis |
| Scientific title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986322 in Participants with Moderate-to-Severe Psoriasis |
| Primary sponsor | Attanasio Massimo |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Australia;Japan;Canada;Japan;Czechia;Japan;France;Japan;Poland;Japan;Spain;Japan;United Kingdom;Japan;United States;Japan |
| Conditions | Moderate-to-Severe Psoriasis |
| Interventions | Double-Blind, Placebo-Controlled, Parallel Group:BMS-986322 4 group randomized(64mg, 32mg, 16mg, Placebo) |
| Registration date | Jun 25, 2023 |
| Target size | 12 |
| Secondary IDs | NCT05730725 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: